Cascinu S - Search Results

1

Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials.

Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M, Morgese F, Torniai M, Savini A, Fiordoliva I, Onofri A, Pistelli M, Taccaliti A, Cascinu S. Berardi R, et al. Among authors: cascinu s. PLoS One. 2016 May 11;11(5):e0152079. doi: 10.1371/journal.pone.0152079. eCollection 2016. PLoS One. 2016. PMID: 27167519 Free PMC article. Review.

2

Adjuvant chemotherapy in gastric cancer. The Italian experience and review of the literature.

Berardi R, Scartozzi M, Galizia E, Cascinu S. Berardi R, et al. Among authors: cascinu s. Suppl Tumori. 2003 Sep-Oct;2(5):S45-7. Suppl Tumori. 2003. PMID: 12914390 Review.

3

Gastric cancer treatment: a systematic review.

Berardi R, Scartozzi M, Romagnoli E, Antognoli S, Cascinu S. Berardi R, et al. Among authors: cascinu s. Oncol Rep. 2004 Apr;11(4):911-6. Oncol Rep. 2004. PMID: 15010894 Review.

4

[Non-small cell lung carcinoma: pathology, biology and prognosis].

Freddari F, Berardi R, Scartozzi M, Cascinu S. Freddari F, et al. Among authors: cascinu s. Suppl Tumori. 2004 Mar-Apr;3(2):S3-4. Suppl Tumori. 2004. PMID: 15067954 Italian. No abstract available.

5

[The DUR studies: colon cancer adjuvants].

Cascinu S, Berardi R. Cascinu S, et al. Suppl Tumori. 2004 Jul-Aug;3(4):S88. Suppl Tumori. 2004. PMID: 15206224 Italian. No abstract available.

6

Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.

Scartozzi M, Galizia E, Freddari F, Berardi R, Cellerino R, Cascinu S. Scartozzi M, et al. Among authors: cascinu s. Cancer Treat Rev. 2004 Aug;30(5):451-9. doi: 10.1016/j.ctrv.2004.01.001. Cancer Treat Rev. 2004. PMID: 15245777 Review.

7

A cost-benefit analysis of chemotherapy for gastric cancer.

Galizia E, Berardi R, Scartozzi M, Cascinu S. Galizia E, et al. Among authors: cascinu s. Expert Opin Pharmacother. 2004 Oct;5(10):2109-14. doi: 10.1517/14656566.5.10.2109. Expert Opin Pharmacother. 2004. PMID: 15461546 Review.

8

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.

Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Fabris G, Cascinu S. Scartozzi M, et al. Among authors: cascinu s. J Clin Oncol. 2004 Dec 1;22(23):4772-8. doi: 10.1200/JCO.2004.00.117. J Clin Oncol. 2004. PMID: 15570078

9

New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.

Berardi R, Verdecchia L, Scartozzi M, Cascinu S. Berardi R, et al. Among authors: cascinu s. JOP. 2005 Jan 13;6(1 Suppl):118-21. JOP. 2005. PMID: 15650296 Review. No abstract available.

10

Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients.

Scartozzi M, Galizia E, Graziano F, Catalano V, Berardi R, Baldelli AM, Testa E, Mari D, Silva RR, Cascinu S. Scartozzi M, et al. Among authors: cascinu s. Br J Cancer. 2005 Mar 28;92(6):1051-4. doi: 10.1038/sj.bjc.6602468. Br J Cancer. 2005. PMID: 15770210 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

658 results

Search Page

Filters